Eureka Therapeutics Announces New GPRC5D License Agreement with Sanofi to Target Multiple Myeloma
Emeryville, California, July 6, 2021 – Eureka Therapeutics, Inc. announced today that Eureka and Memorial Sloan Kettering Cancer Center (MSK) entered into a license agreement with Sanofi

